New multiplex real-time PCR kits detect clinically relevant β-lactamase genes
β-lactamase enzymes inactivate β-lactam antibiotics and render them ineffective for the treatment of clinically-important Gram-negative bacterial infections. Now, two new kits from Streck Inc. provide a comprehensive, cost-effective molecular method to detect the most clinically-important β-lactamases that confer resistance to penicillins, cephamycins, and in some cases, carbapenems. The antibiotic resistance monitoring and detection (ARM-D) kits, […]
